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        Introduction 
  Cell migration is a highly regulated process that involves the 
continuous formation and turnover of cell  –  substratum contact 
sites termed focal adhesions (FAs), which serve as points of trac-
tion and as signaling centers (  Ridley et al., 2003  ;   Romer et al., 
2006  ). FAs, which link integrins to the actin cytoskeleton, con-
trol the migratory potential of cells (  Geiger and Bershadsky, 
2001 ;  Webb et al., 2003 ). Despite the importance of regulated FA 
formation and turnover in cell migration, the molecular mecha-
nisms controlling these events remain loosely defi  ned (  Vicente-
Manzanares et al., 2005  ;   Moissoglu and Schwartz, 2006  ). 
 Rho family GTPases are molecular switches involved in the 
regulation of many cellular processes. The RhoGTPase members 
Rho, Rac, and Cdc42 control signaling pathways regulating actin 
and FA assembly or disassembly (  Hall, 2005  ). RhoA promotes 
stress fi  ber and FA formation, in part through Rho kinase – mediated 
cell contractility. Temporal regulation of RhoA is important, 
as constitutively active RhoA impedes cell motility, in part 
through enhanced FA formation. Integrin binding to fi  bronectin 
(FN) generates intracellular signals, leading to the transient in-
hibition of RhoA followed by extended RhoA reactivation (  Ren 
et al., 1999  ). Rho GTPases are activated by guanine nucleotide 
exchange factors (GEFs), which catalyze the exchange of GDP 
for GTP (  Rossman et al., 2005  ;   Bos et al., 2007  ). Rho GTPases 
return to an inactive state upon hydrolysis of GTP to GDP, a 
I
ntegrin binding to matrix proteins such as ﬁ  bronectin 
(FN) leads to formation of focal adhesion (FA) cellular 
contact sites that regulate migration. RhoA GTPases 
facilitate FA formation, yet FA-associated RhoA-speciﬁ  c 
guanine nucleotide exchange factors (GEFs) remain un-
known. Here, we show that proline-rich kinase-2 (Pyk2) 
levels increase upon loss of focal adhesion kinase (FAK) 
in mouse embryonic ﬁ  broblasts (MEFs). Additionally, we 
demonstrate that Pyk2 facilitates deregulated RhoA acti-
vation, elevated FA formation, and enhanced cell prolifer-
ation by promoting p190RhoGEF expression. In normal 
MEFs, p190RhoGEF knockdown inhibits FN-associated 
RhoA activation, FA formation, and cell migration. Knock-
down of p190RhoGEF-related GEFH1 does not affect FA 
formation in FAK
      /      or normal MEFs. p190RhoGEF over-
expression enhances RhoA activation and FA formation in 
MEFs dependent on FAK binding and associated with 
p190RhoGEF FA recruitment and tyrosine phosphory-
lation. These studies elucidate a compensatory function 
for Pyk2 upon FAK loss and identify the FAK  –  p190RhoGEF 
complex as an important integrin-proximal regulator of 
FA formation during FN-stimulated cell motility.
  PyK2 and FAK connections to p190Rho guanine 
nucleotide exchange factor regulate RhoA activity, 
focal adhesion formation, and cell motility 
    Yangmi     Lim  ,   
1       Ssang-Taek     Lim  ,   
1       Alok     Tomar  ,   
1       Margaret     Gardel  ,   
2       Joie A.     Bernard-Triﬁ  lo  ,   
3       Xiao Lei     Chen  ,   
1     
  Sean A.     Uryu  ,   
1       Rafaela     Canete-Soler  ,   
4       Jinbin     Zhai  ,   
4       Hong     Lin  ,   
4       William W.     Schlaepfer  ,   
4       Perihan     Nalbant  ,   
5     
  Gary     Bokoch  ,   
5       Dusko     Ilic  ,   
6       Clare     Waterman-Storer  ,   
7     and   David D.     Schlaepfer     
1     
   
1  Department of Reproductive Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093 
   
2  Department of Physics, University of Chicago, Chicago, IL 60637 
   
3  Millipore Biosciences, Temecula, CA 92590 
   
4  Division of Neuropathology, University of Pennsylvania, Philadelphia, PA 19104 
   
5  Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037 
   
6  StemLifeLine Inc., San Carlos, CA 94070 
   
7  Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892     JCB • VOLUME 180 • NUMBER 1 • 2008  188
  Figure 1.       Pyk2 knockdown affects FAK   
     /         MEF morphology, FA formation, and paxillin tyrosine phosphorylation.   (A and B) Compensatory increase in 
Pyk2 levels upon inactivation of FAK expression. Lysates from FAK 
+/+  , FAK 
    /     , and FAK 
+/+(loxP/loxP)   MEFs were analyzed by anti-FAK, Pyk2, Cre recombinase, 
and paxilllin blotting. Lysates from Ad-Cre  –  infected FAK 
+/+(loxP/loxP)   MEFs were analyzed after 48 h or 7 d. Paxillin levels were used as a loading control. 
(B) Human diploid ﬁ  broblasts were treated with lentiviral Scr or FAK shRNA and protein lysates were evaluated by anti-FAK, Pyk2, and actin blotting after 7 d. 
(C) Stable Pyk2 reduction in FAK 
    /      MEFs by lentiviral anti-Pyk2 shRNA expression. Lysates from the indicated MEFs were analyzed by antiphosphotyrosine 
(pY), Pyk2, actin, and GFP blotting. (D) Phase-contrast images show that FAK 
    /      Pyk2 shRNA MEFs exhibit more of a ﬁ  broblast phenotype than FAK 
    /      189 PYK2 AND FAK CONNECTIONS TO   P  190R  HO  GEF   •   LIM ET AL.
Scr shRNA control MEFs. Bars, 30   μ  m. (E) F-actin was reduced and fewer FAs formed in FN-replated (60 min) FAK 
    /      Pyk2 shRNA compared with FAK 
    /      
Scr shRNA MEFs as determined by phalloidin and anti-paxillin costaining, respectively. Alexa Fluor 350 phalloidin stain is pseudocolored green. Bar, 
20   μ  m. (F) Increased FAK 
    /      FA size upon reduced Pyk2 expression. Box-and-whisker plots of paxillin-stained area within FAK 
    /      Scr shRNA or FAK 
    /      Pyk2 
shRNA MEFs plated on FN for 60 min (  n   = 15 cells per point). Box-and-whisker diagrams show the distribution of the data: square, mean; bottom line, 25th 
percentile; middle line, median; top line, 75th percentile; and whiskers, 5th or 95th percentiles. This representation applies for all box-and-whisker plots 
in this paper. (G) Decreased FAK 
    /      FA formation upon reduced Pyk2 expression. Box-and-whisker plots of paxillin-positive  –  stained points within FAK 
    /      
Scr shRNA or FAK 
    /      Pyk2 shRNA MEFs plated on FN for 60 min (  n   = 15 cells per point). (H) Decreased FAK 
    /      F-actin accumulation upon reduced Pyk2 
expression. Relative Alexa Fluor phalloidin staining per FAK 
    /      Scr shRNA MEF (set to 100) and FAK 
    /      Pyk2 shRNA MEF upon FN plating (60 min; 
  n   = 15 cells per point). Error bars represent the SD. (I) Replating assays with FAK 
    /      Scr or FAK 
    /      Pyk2 shRNA MEFs show differences in FN-stimulated 
paxillin Y118 phosphorylation. Lysates from serum-starved cells, cells held in suspension (45 min), or cells replated with FN for the indicated times were 
analyzed by antiphosphotyrosine blotting. Paxillin immunoprecipitations from the same lysates were sequentially analyzed by anti-paxillin phosphotyrosine 
118 phosphospeciﬁ  c and paxillin blotting.     
 
reaction enhanced by GTPase-activating proteins (GAPs). Tran-
sient inhibition of RhoA during FN adhesion is mediated in part 
by the Src family protein tyrosine kinase (PTK) phosphorylation 
of p190RhoGAP, which leads to elevated RhoGAP activity ( Arthur 
et al., 2000  ). The GEFs important in facilitating RhoA reactiva-
tion and FA formation upon FN adhesion remain unknown. 
  Many PTKs facilitate Rac- and Cdc42-specific GEF 
activation, whereas Rho-specifi  c GEF activation by PTKs is less 
common (  Schiller, 2006  ). FAK activation by integrins facilitates 
the recruitment of Src family PTKs into a signaling complex 
localized to FAs (  Mitra et al., 2005  ;   Mitra and Schlaepfer, 2006  ). 
FAK- or Src-mediated tyrosine phosphorylation of various 
RhoGEFs is associated with RhoA activation (  Chikumi et al., 
2002  ;   Medley et al., 2003  ;   Zhai et al., 2003  ), but it remains 
unclear whether these events are linked to FA formation or the 
regulation of cell motility. An unexplained phenomenon is that 
FAK-null (FAK 
   /   ) mouse embryonic fi  broblasts (MEFs) exhibit 
constitutively high RhoA activity, enhanced FA formation, and 
refractory cell motility responses (  Ilic et al., 1995  ;   Owen et al., 
1999  ;   Sieg et al., 1999  ;   Ren et al., 2000  ). Inhibition of RhoA 
(  Ren et al., 2000  ) or Rho kinase (  Chen et al., 2002  ) in FAK 
   /    
MEFs decreases FA formation. Although FAK can suppress 
RhoA activity via p190RhoGAP tyrosine phosphorylation 
( Holinstat et al., 2006 ), it is unclear whether loss of FAK accounts 
for constitutive RhoA activation. Alternatively, expression of the 
FAK-related proline-rich kinase 2 (Pyk2) PTK is elevated in 
FAK 
   /    MEFs ( Sieg et al., 1998 ), but the role of Pyk2 in FAK 
   /    
MEFs remains undefi  ned. 
  In this paper, we show that Pyk2 promotes FAK 
   /     MEF 
proliferation and aberrant FA formation through the regula-
tion of p190RhoGEF expression affecting RhoA activation. 
p190RhoGEF is a ubiquitously expressed RhoA-specifi  c GEF 
that can bind microtubules and also associates with FAK (  Gebbink 
et al., 1997 ;  van Horck et al., 2001 ;  Zhai et al., 2003 ). In FAK 
   /    
MEFs, Pyk2 associates with p190RhoGEF, and knockdown 
of Pyk2 or p190RhoGEF results in FAK 
   /     MEFs with normal 
FN-associated RhoA regulation but extreme motility and trailing-
edge retraction defects. These fi  ndings show that some FAK-
null phenotypes are caused by compensatory Pyk2 signaling 
effects. In normal MEFs with FAK and little Pyk2, p190Rho  GEF 
knockdown limits RhoA activation, FA formation, and cell 
motility on FN. Knockdown of p190RhoGEF-related GEFH1 
(  Ren et al., 1998  ;   Rossman et al., 2005  ) was without effects 
on FA formation in FAK 
   /     and normal MEFs. As deletion of 
the p190RhoGEF FAK-binding region prevents p190RhoGEF 
localization to FAs, inhibits p190RhoGEF-associated RhoA 
activation and FA formation, and blocks integrin-stimulated 
p190RhoGEF tyrosine phosphorylation, our studies have iden-
tified the FAK  –  p190RhoGEF signaling complex as an im-
portant integrin-proximal regulator of FA formation during 
cell migration. 
  Results 
  Compensatory Pyk2 expression upon FAK 
loss in mouse and human ﬁ  broblasts 
 FAK 
   /     MEFs exhibit elevated Pyk2 expression (  Sieg et al., 
1998  ), and it has been proposed that this may refl  ect genetic in-
stability associated with p53 coinactivation (  Tilghman et al., 
2005  ). To determine whether Pyk2 levels change upon FAK 
inactivation in culture, primary FAK 
(loxP/loxP)   MEFs were trans-
duced with adenoviral (Ad) Cre-recombinase and FAK-Pyk2 
levels were monitored by immunoblotting (  Fig. 1 A  ). High Cre 
levels were observed within 48 h of transduction with slight re-
duction of FAK but no changes in Pyk2 expression. Loss of 
FAK was complete by day 7 after Ad-Cre transduction at which 
time Pyk2 levels were greatly elevated (  Fig. 1 A  ). To determine 
whether this compensatory change in Pyk2 occurs in other cells, 
human diploid fi  broblasts were infected with scrambled (Scr) 
or anti-FAK short hairpin RNA (shRNA) lentivirus (  Fig. 1 B  ). 
After 7 d, FAK expression was selectively inhibited by FAK 
shRNA expression and Pyk2 levels were greatly elevated rela-
tive to actin and control Scr shRNA  –  expressing cells. Although 
stable FAK shRNA  –  mediated knockdown in various tumor cell 
lines did not result in alterations in Pyk2 expression (  Mitra 
et  al., 2006a,b  ), compensatory Pyk2 expression occurs upon 
loss of FAK in MEFs and human fi  broblasts. 
  Pyk2 knockdown in FAK     
   /          MEFs reduces 
FA formation and paxillin tyrosine 
phosphorylation 
  To elucidate the role of Pyk2 in FAK 
   /     MEFs, Pyk2 ex  pression 
was inhibited by lentiviral-mediated Pyk2-specifi  c shRNA ( Fig. 1 C ). 
The shRNA lentivirus coexpresses GFP, and FAK 
   /     vector-
only, Scr, or Pyk2 shRNA MEF pooled cell populations were en-
riched by FACS. Stable Pyk2 knockdown of     90% in FAK 
   /    
Pyk2 shRNA MEFs resulted in cells with a normal fi  broblast-like 
phenotype compared with the more rounded FAK 
   /     parental 
(not depicted) or control FAK 
   /     Scr shRNA MEFs (  Fig. 1 D  ). 
When plated onto FN for 60 min, Scr shRNA and Pyk2 shRNA 
FAK 
   /     MEFs were equally spread (  Fig. 1 E  ), but cells with 
less Pyk2 formed fewer FAs of larger size (  Fig. 1, F and G  ) and JCB • VOLUME 180 • NUMBER 1 • 2008  190
  Pyk2 promotes FAK     
   /          MEF proliferation, 
but not motility, at a level equal to FAK 
  FAK signaling can promote cell cycle progression (  Zhao et al., 
2003 ),  but  FAK 
   /     MEFs do not exhibit proliferation defects in 
culture compared with FAK-reconstituted (clone DP3) and nor-
mal FAK 
+/+   MEFs (  Fig. 2 A  ). Analyses of FAK 
   /     Scr shRNA 
MEFs showed no differences in growth compared with control 
FAK 
   /     MEFs (  Fig. 2, A and B  ), whereas FAK 
   /     Pyk2 shRNA 
MEFs grow slower than FAK 
   /     Scr and vector shRNA controls 
(  Fig. 2 B  ). Importantly, transient Ad-FAK or human Ad-Pyk2 
expression in FAK 
   /     Pyk2 shRNA MEFs enhanced cell prolif-
eration at a level equivalent to FAK 
   /     controls (  Fig. 2, C and D  ). 
  Figure 2.       Pyk2 facilitates FAK   
     /         MEFs  ’   pro-
liferation and motility.   (A) FAK 
    /     , FAK 
+/+  , and 
FAK-reconstituted (DP3) MEF proliferation was 
evaluated over 5 d and shows that FAK 
    /      MEFs 
do not exhibit growth defects. (B) FAK 
    /      vector, 
FAK 
    /      Scr shRNA, and FAK 
    /      Pyk2 shRNA MEF 
proliferation was evaluated over 5 d and shows 
that Pyk2 shRNA expression is associated with 
reduced growth. (C) Transient Ad-FAK or Ad-Pyk2 
expression enhances FAK 
    /      Pyk2 shRNA MEF 
proliferation. Cells were infected for 24 h with 
the indicated control Ad-TA, Ad-FAK, or Ad-Pyk2 
constructs before initiating growth analyses. Val-
ues in A  –  C are means   ±   SD of three experiments. 
(D) Lysates from FAK 
    /      vector and Pyk2 shRNA 
MEFs infected with Ad-FAK or Ad-Pyk2 were re-
solved by SDS-PAGE and analyzed by HA-tag, 
Pyk2, and actin blotting. (E) FAK promotes FAK 
    /      
MEF motility better than Pyk2. The indicated MEFs 
were analyzed for 10-  μ  g/ml-FN  –  stimulated Boy-
den chamber motility over 4 h and values are ex-
pressed as a percentage of FAK 
    /      vector control 
(set to 100). As indicated, FAK 
    /      vector shRNA 
or FAK 
    /      Pyk2 shRNA MEFs were infected with 
Ad-FAK or Ad-Pyk2 for 48 h and analyzed for mo-
tility responses. Values   ±   SD are from three sepa-
rate experiments.     
contained less polymerized F-actin compared with control FAK 
   /    
Scr shRNA MEFs (  Fig. 1 H  ). The number and size of FAs in 
FAK 
   /    Pyk2 shRNA MEFs was equivalent to normal MEFs (un-
published data). Tyrosine phosphorylation of the FA-associated 
protein paxillin is elevated in FAK 
   /     compared with normal 
MEFs (  Ilic et al., 1995  ), and this was reduced by Pyk2 shRNA 
expression in growing (  Fig. 1 C  ) and FN-plated FAK 
   /     MEFs 
(  Fig. 1 I  ). As these changes in FAK 
   /     Pyk2 shRNA MEFs were 
not associated with alterations in    5,     1, or    v  integrin  subunit 
surface expression (unpublished data), our data support the no-
tion that Pyk2 facilitates enhanced FA formation and paxillin 
tyrosine phosphorylation in FAK 
   /     MEFs. 191 PYK2 AND FAK CONNECTIONS TO   P  190R  HO  GEF   •   LIM ET AL.
ordinated cell contraction associated with trailing-tail region 
release (  Fig. 3 A   and Video 1). FAK 
   /     MEFs exhibit membrane 
ruffl  ing  in  all directions and limited directional movement 
(Video 2). Although reduced Pyk2 expression prevents exces-
sive FA formation (  Fig. 1  ), when FAK 
   /     Pyk2 shRNA MEFs 
moved in one direction, cells became very stretched, pieces 
broke off, and movement occurred in a snapping fashion (  Fig. 3 B   
and Video 3). This snapping phenotype was rescued by FAK 
re  expression (unpublished data). These results are consistent 
with the inability of FAK 
   /     Pyk2 shRNA MEFs to facilitate 
trailing-edge FA release as FAK 
   /     MEFs exhibit decreased 
FA turnover dynamics (  Ren et al., 2000  ;   Webb et al., 2004  ). 
Moreover, these results show that compensatory Pyk2 expression 
is not causal for FAK 
   /     MEF motility defects. 
  The connection between Pyk2 and 
RhoA activation 
 The regulation of FA formation is, in part, associated with RhoA 
GTPase activation. MEF binding and spreading on FN results in 
These results support the conclusion that compensatory Pyk2 
expression within FAK 
   /     MEFs promotes cell growth. 
  In addition to growing slower, FAK 
   /     Pyk2 shRNA MEFs 
exhibit severe motility defects in wound-healing assays under 
conditions where control FAK 
   /     MEFs achieve wound closure 
(Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb
.200708194/DC1). In FN-stimulated Boyden chamber motil-
ity assays, FAK 
   /     Pyk2 shRNA MEFs exhibited virtually no 
motility (  Fig. 2 E  ). Importantly, transient Ad-FAK expression 
could rescue the motility defect of FAK 
   /     Pyk2 shRNA MEFs 
to     75% of the level of FAK-reconstituted (DP3) or FAK 
+/+  
MEFs and twice the level of FAK 
   /    controls ( Fig. 2 E ). Notably, 
Ad-Pyk2 overexpression only weakly promoted FAK 
   /     Pyk2 
shRNA MEF motility to     70% of the level of FAK 
   /     controls 
(  Fig. 2 E  ). Time-lapse microscopy revealed that FAK 
   /     Pyk2 
shRNA MEFs spread on FN but exhibited limited random move-
ment compared with FAK-reconstituted MEFs (  Fig. 3, A and B  ; 
and Fig. S2). Normal and FAK-reconstituted MEF movement 
is characterized by leading lamellipodia protrusions with co-
  Figure 3.       FAK   
     /         Pyk2 shRNA MEFs exhibit tail-retraction 
motility defects.   (A) FAK-reconstituted DP3 MEFs were plated on 
1   μ  g/ml FN and monitored for random cell motility in 10% FBS 
over the indicated time (images obtained from Video1, available 
at http://www.jcb.org/cgi/content/full/jcb.200708194/DC1). 
Cells show normal protrusive activity at the leading edge and 
coordinated tail retraction (arrows) as the cell moves forward. 
Bar, 30   μ  m. (B) FAK 
    /      Pyk2 shRNA MEFs on 1   μ  g/ml FN exhibit 
membrane-rufﬂ  ing activity in the presence of 10% FBS (images 
obtained from Video 3). Efﬁ   cient motility does not occur as 
cells exhibit defects in tail-associated FA release (arrows). A cell-
snapping phenotype is common with pieces of cell material left 
behind. Bar, 30   μ  m.     JCB • VOLUME 180 • NUMBER 1 • 2008  192
elevated RhoA-GTP levels in suspension (  Fig. 4 A  ). In FAK 
   /    
MEFs, RhoA-GTP levels remain high upon initial cell binding 
to FN (15 and 30 min), whereas RhoA-GTP levels are low when 
FAK 
+/+   MEFs bind to FN (  Fig. 4, A and B  ). By 90 min, RhoA-
GTP levels are equally elevated in FAK 
   /     and FAK 
+/+   MEFs. 
Plating FAK 
   /     Pyk2 shRNA MEFs on FN revealed the transient 
the transient inhibition of RhoA at 15  –  30 min, followed by an 
extended phase of RhoA activation associated with FA forma-
tion and maturation (  Ren et al., 1999  ;   Vicente-Manzanares et al., 
2005 ).  An  affi  nity binding assay can be used to determine the 
amount of activated RhoA-GTP as a function of total RhoA 
(  Ren et al., 1999  ). Both FAK 
   /     and  FAK 
+/+   MEFs  exhibit 
  Figure 4.       Pyk2 signaling activates RhoA and promotes p190RhoGEF expression.   (A) Pyk2 knockdown restores normal RhoA regulation during FN adhe-
sion of FAK 
    /      MEFs. RhoA activation analyses were performed using the indicated serum-starved MEFs held in suspension for 30 min and then replated 
on 10   μ  g/ml FN for the indicated times. GTP-bound RhoA was determined by GST-RBD pulldown and blotting for RhoA levels in lysates. (B) Quantita-
tion of FN-associated RhoA-GTP binding. RhoA values are means   ±   SD of three independent experiments and are plotted relative to RhoA-GTP levels in 
suspended FAK 
    /      vector shRNA MEFs. (C) Pyk2 kinase activity and Y402 phosphorylation are required to promote Rho activation. FAK 
    /      Pyk2 shRNA 
MEFs were preinfected with Ad-TA control, Myc-Pyk2 WT, Myc-Pyk2 F402, or Myc-Pyk2 A457 (kinase inactive), subjected to FN replating, and analyzed 
for Rho-GTP binding as in A. (D) Quantitation of FN-stimulated RhoA-GTP binding from C. Values are means   ±   SD of two independent experiments and 
are plotted relative to RhoA-GTP levels in suspended FAK 
    /      Pyk2 shRNA MEFs. (E) Elevated p190RhoGEF mRNA levels in FAK 
    /      MEFs. RT-PCR analyses 
using p190RhoGEF- and     -actin  –  speciﬁ  c primers. Shown is an inverted ethidium bromide  –  stained gel. (F) p190RhoGEF protein expression is regulated by 
Pyk2. FAK 
    /      Pyk2 shRNA MEFs were infected with Ad-FAK or Ad-Pyk2 for 48 h. p190RhoGEF or actin protein expression were analyzed by blotting and 
compared with lysates from FAK 
+/+   and FAK 
    /      MEFs. (G) Kinase- and Y402-dependent Pyk2 signaling promotes Pyk2 expression. FAK 
    /      Pyk2 shRNA 
MEFs were infected with Ad-TA control, Ad-Pyk2 WT, Ad-Pyk2 F402, or Ad-Pyk2 A457 for 48 h. p190RhoGEF, Pyk2, and actin expression were analyzed 
by blotting.     193 PYK2 AND FAK CONNECTIONS TO   P  190R  HO  GEF   •   LIM ET AL.
possessed leading-edge membrane  –  ruffl  ing activity but exhibited 
limited directional movement upon serum stimulation (Fig. S2 
and Video 4, available at http://www.jcb.org/cgi/content/full/jcb
.200708194/DC1). These results support a role for p190Rho GEF 
in MEF motility. Additionally, as FAK 
   /     p190RhoGEF  shRNA 
MEFs form FAs within 60 min on FN (  Fig. 5 B  ) under condi-
tions of low RhoA-GTP binding (  Fig. 5 D  ), our results support 
the notion that FA formation can also occur through alternative 
pathways (  Zaidel-Bar et al., 2004  ) and that low levels of RhoA 
activity in FAK 
   /     p190RhoGEF shRNA MEFs likely represent 
contributions of other GEFs downstream of integrins. 
  To determine whether p190RhoGEF contributes to FAK 
   /    
growth, cell proliferation assays were performed. FAK 
   /    
p190RhoGEF shRNA MEFs grew signifi  cantly (P  <  0.01 at day 3) 
slower than FAK 
   /     Scr shRNA MEFs (  Fig. 5 F  ). Rescue assays 
were inconclusive because of shRNA inhibition of mouse 
p190RhoGEF reexpression (unpublished data). Interestingly, 
Ad-Pyk2 overexpression did not signifi  cantly promote FAK 
   /    
p190RhoGEF shRNA MEF growth (  Fig. 5 F  ; P   >   0.05) and only 
weakly facilitated RhoA-GTP binding upon FN plating (  Fig. 5 G  ). 
This result contrasts with strong RhoA activation (  Fig. 4 C  ) and 
increased cell proliferation (  Fig. 2 C  ) upon Pyk2 reexpression 
within FAK 
   /     Pyk2 shRNA MEFs. This result supports the 
conclusion that a Pyk2-p190RhoGEF signaling linkage promotes 
FAK 
   /     MEF proliferation and that p190RhoGEF is an impor-
tant target for Pyk2-mediated RhoA activation. 
  p190RhoGEF functions downstream of 
integrins in normal MEFs 
  It is well established that Rho GTPase activation and cell con-
tractility contribute to FA formation (  Wehrle-Haller and Imhof, 
2002  ;   Zaidel-Bar et al., 2003  ). However, it remains unclear 
which GEFs downstream of integrins participate in this process. 
Lentiviral p190RhoGEF shRNA was used to stably reduce 
p190RhoGEF levels in normal (FAK 
+/+  ) MEFs (  Fig. 6 A  ), and 
this resulted in the inhibition of RhoA activation at 90 and 
120 min after FN plating compared with parental and Scr shRNA  –
  expressing MEFs (  Fig. 6, B and C  ). FAK 
+/+   MEFs with reduced 
p190RhoGEF did not show differences in binding to or spread-
ing on FN. At 60 min on FN, FAK 
+/+   p190RhoGEF shRNA MEFs 
were fully spread but contained greater than twofold fewer FAs 
per cell than control FAK 
+/+   Scr MEFs (  Fig. 6, D and E  ). This 
difference in FA formation upon p190RhoGEF reduction was 
also associated with the inhibition of FN-stimulated motility 
(  Fig. 6 F  ). These results support the notion that p190RhoGEF 
functions as an important regulator of RhoA activity and FA 
formation downstream of integrins. 
  To evaluate the specifi  city of p190RhoGEF action, tran-
sient siRNA knockdowns were performed with a closely related 
(  Rossman et al., 2005  ) RhoA-specifi   c GEF termed GEFH1 
(  Ren et al., 1998  ). Effi  cient GEFH1 knockdown was accom-
plished in both FAK 
   /     and FAK 
+/+   MEFs, but there were no 
differences in paxillin-stained FAs or actin structures upon loss 
of GEFH1 (Fig. S3, available at http://www.jcb.org/cgi/content/
full/jcb.200708194/DC1). Alternatively, transient GFP-GEFH1 
expression revealed a circular microtubule distribution consis-
tent with GEFH1 binding to microtubules (  Ren et al., 1998  ), 
inhibition of RhoA-GTP levels, which is similar to RhoA regu-
lation in FAK 
+/+   MEFs (  Fig. 4, A and B  ). This result supports 
the notion that Pyk2 is facilitating aberrant RhoA activation in 
FAK 
   /     MEFs. 
  To determine whether Pyk2 signaling promotes RhoA 
activation, FAK 
   /     Pyk2 shRNA MEFs were transduced with 
either human Ad-Pyk2 wild type (WT), Ad-Pyk2 A457 (kinase 
dead), or Ad-Pyk2 F402 or Ad  –  tetracycline transactivator (TA; 
control), and RhoA activity was evaluated after FN replating 
(  Fig. 4 C  ). Ad-Pyk2 WT promoted constitutively activated 
RhoA, which is similar to what occurs in FAK 
   /     MEFs (  Fig. 4, 
A and C  ). Expression of Pyk2 kinase dead or Pyk2 F402 had 
slight inhibitory effects on RhoA regulation upon FN plating 
(  Fig. 4, C and D  ). Collectively, these results show that Pyk2 
kinase activity and Pyk2 Y402 phosphorylation are needed to 
facilitate RhoA activation in FAK 
   /     MEFs. 
  Pyk2 regulates p190RhoGEF expression 
  Integrin-induced RhoA regulation is compromised in Pyk2 
   /    
macrophages (  Okigaki et al., 2003  ) but the signaling linkage 
between Pyk2 and RhoA remains undefi  ned. GEFs function as 
RhoGTPase activators (  Rossman et al., 2005  ), and we previ-
ously identified p190RhoGEF as a FAK-binding partner in-
volved in laminin-stimulated RhoA activation in neuronal cells 
(  Zhai et al., 2003  ). p190RhoGEF is a ubiquitously expressed 
RhoA-specifi  c GEF of unclear biological function (  Gebbink 
et al., 1997 ;  van Horck et al., 2001 ). By semiquantitative RT-PCR 
analyses, low levels of p190RhoGEF mRNA were detected in 
FAK 
+/+   MEFs, whereas more than fi  vefold higher p190RhoGEF 
mRNA levels were present in FAK 
   /     MEFs (  Fig. 4 E  ). By pro-
tein blotting, p190RhoGEF expression was three- to fourfold 
higher in FAK 
   /     compared with FAK 
+/+   MEFs, and Pyk2 
shRNA expression was associated with reduced p190RhoGEF 
levels in FAK 
   /     MEFs (  Fig. 4 F  ). Transient Ad-Pyk2, but not 
Ad-FAK, expression increased p190RhoGEF mRNA (not de-
picted) and protein levels about twofold by 48 h in FAK 
   /    
Pyk2 shRNA MEFs (  Fig. 4 F  ). This increase in p190RhoGEF 
protein was dependent on intrinsic Pyk2 kinase activity and 
Y402 phosphorylation (  Fig. 4 G  ). These results show that Pyk2 
signaling controls p190RhoGEF expression in FAK 
   /     MEFs, 
and this linkage is also conserved in rat pheochromocytoma 
PC12 cells (unpublished data). 
  p190RhoGEF promotes deregulated RhoA 
activity and growth of FAK     
   /          MEFs 
  To determine the function of p190RhoGEF in FAK 
   /     MEFs, 
lentiviral-mediated shRNA was used to stably knock down 
p190RhoGEF expression   >  85% (  Fig. 5 A  ). Strikingly, FAK 
   /    
p190RhoGEF shRNA MEFs exhibited a conversion from an 
epithelial-like to a fi  broblast morphology and formed fewer FAs 
than FAK 
   /     Scr shRNA MEFs upon FN plating (  Fig. 5, B and C  ). 
Reduction in p190RhoGEF was also associated with the ces-
sation of deregulated RhoA activity in FAK 
   /     MEFs (  Fig. 5 D  ). 
Despite the relatively normal appearance of FAK 
   /    p190RhoGEF 
shRNA MEFs, Boyden chamber FN motility assays revealed 
severe motility defects ( Fig. 5 E ). Time-lapse microscopy showed 
that FAK 
   /     p190RhoGEF shRNA MEFs spread on FN and JCB • VOLUME 180 • NUMBER 1 • 2008  194
  Figure 5.       p190RhoGEF contributes to aberrant FAK   
     /         MEF morphology, RhoA activity, and FA formation.   (A) Stable p190RhoGEF knockdown. FAK 
    /      
MEFs were infected with lentiviral Scr or p190RhoGEF shRNA and sorted for GFP expression, and lysates were analyzed by p190RhoGEF, Pyk2, actin, 
and GFP blotting. (B) Phase-contrast images show that FAK 
    /      p190RhoGEF shRNA MEFs exhibit more of a ﬁ  broblast phenotype than FAK 
    /      Scr shRNA 
control MEFs. Reduced numbers of FAs connected to F-actin after FN replating (60 min) upon p190RhoGEF knockdown as determined by anti-paxillin 
and Alexa Fluor 350 phalloidin costaining. Bars, 30   μ  m. (C) Decreased FAK 
    /      FA formation upon p190RhoGEF knockdown. Box-and-whisker plots 
of paxillin-positive  –  stained points within FAK 
    /      Scr shRNA or FAK 
    /      p190RhoGEF shRNA MEFs plated on FN for 60 min (  n   = 15 cells per point). 
(D) p190RhoGEF knockdown prevents deregulated FAK 
    /      MEF RhoA activation. GTP-bound RhoA was determined by GST-RBD pulldown assays from 
lysates of suspended and FN-replated FAK 
    /      Scr shRNA and FAK 
    /      p190RhoGEF shRNA MEFs followed by blotting for total RhoA levels. (E) Loss 
of p190RhoGEF inhibits motility. 10-  μ  g/ml-FN  –  stimulated FAK 
+/+  , FAK 
    /      Scr, and FAK 
    /      p190RhoGEF shRNA MEF Boyden chamber motility over 4 h. 
Means   ±   SD were determined from three experiments and are a percentage of FAK 
    /      control (set to 100). (F) p190RhoGEF contributes to FAK 
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but not FA localized, p190RhoGEF activity required FAK bind-
ing and FA association in normal MEFs. 
  To determine if FA localization of p190RhoGEF is essen-
tial for its effects on FA formation, GFP-p190RhoGEF was 
transiently expressed in FAK 
   /     MEFs. Surprisingly, GFP-
p190RhoGEF was not FA localized but exhibited potent effects 
on enhancing FA formation (  Fig. 9 A  ). By coimmunoprecipita-
tion analyses, endogenous p190RhoGEF forms a complex with 
Pyk2 in FAK 
   /     MEFs (  Fig. 9 B  ) and is tyrosine phosphory-
lated upon FN plating (  Fig. 9 C  ). Importantly, Pyk2 also does 
not localize to FAs in FAK 
   /     MEFs (  Sieg et al., 1998  ). How-
ever, as GFP-p190RhoGEF did not function to promote FA 
formation or localize to FAs in FAK 
   /     Pyk2 shRNA MEFs 
(unpublished data), these results are consistent with the impor-
tance of FAK in mediating p190RhoGEF FA localization and with 
potentially overlapping roles for Pyk2 or FAK in promoting 
p190RhoGEF tyrosine phosphorylation and activation. In vitro 
kinase assays using purifi  ed Pyk2 or FAK kinase domains or 
full-length Src showed that each of these PTKs could directly 
phosphorylate p190RhoGEF (Fig. S5, available at http://www
.jcb.org/cgi/content/full/jcb.200708194/DC1). Analysis of GFP-
p190RhoGEF – expressing  FAK 
+/+   MEFs revealed adhesion-
dependent p190RhoGEF WT tyrosine phosphorylation and the 
formation  of  a  FAK – paxillin – p190RhoGEF  signaling  complex 
(  Fig. 9 D  ). FAK association and p190RhoGEF tyrosine phos-
phorylation upon FN plating were inhibited by p190RhoGEF 
catalytically inactivating (Y1003A) mutation or deletion of the 
FAK-binding region (    1292-1301). Together, these results sup-
port the notion that p190RhoGEF activity is regulated in part by 
FAK and or Pyk2 binding leading to enhanced p190RhoGEF 
tyrosine phosphorylation and the formation of an adhesion-
dependent signaling complex. 
  Discussion 
  Many investigators have compared FAK 
+/+   and FAK 
   /     MEFs to 
defi  ne the role of FAK in various signaling pathways (  Mitra et al., 
2005  ). One complication of these analyses is that expression of 
the FAK-related PTK Pyk2 is elevated in FAK 
   /     MEFs. We  show 
that increased Pyk2 expression occurs after conditional FAK in-
activation within FAK 
(loxP/loxP)   MEFs and upon FAK knockdown 
by shRNA expression within human diploid fi  broblasts. The same 
shRNA was used to knock down FAK within human MCF-7 and 
MDA-MB-231 breast carcinoma, PC3 prostate carcinoma, or 
NB8 neuroblastoma cells without detectable changes in Pyk2 ex-
pression (  Mitra et al., 2006a  ,  b  ). Thus, compensatory changes in 
Pyk2 levels are independent of the means to inactivate FAK and 
may refl  ect differences in cell origin or transformation. 
  We found that Pyk2 shRNA knockdown within FAK 
   /    
MEFs slows cell growth that could be rescued by either transient 
FAK or Pyk2 reexpression. Previous studies have linked FAK 
whereas expression of GFP-p190RhoGEF was cytoplasmic dis-
tributed and selectively enriched within the tips of cell projec-
tions in normal MEFs (Fig. S4). Both GEFs enhanced F-actin 
generation and this was inhibited by GEF-inactivating point 
mutations in the catalytic domains of GEFFH1 (Y393A) and 
p190RhoGEF (Y1003A; unpublished data). 
  To explore the similarities and differences of these GEFs, 
GFP fusions of GEFH1 WT (or catalytically inactive Y393A 
GEFH1) and p190RhoGEF (or catalytically inactive Y1003A 
or     1292-1301, a FAK-binding mutant) were stably expressed 
in normal MEFs via lentiviral transduction (  Fig. 7 A  ). GFP  –
  p190RhoGEF WT and Y1003A were expressed at levels equiva-
lent to endogenous p190RhoGEF (not depicted), whereas GFP  – 
GEFH1 WT expression was low (  Fig. 7 A  ) and associated with a 
rounded and multinucleated phenotype, which is consistent with a 
role for GEFH1 in cytokinesis ( Birkenfeld et al., 2007 ). GFP-GEFH1 
and GFP-p190RhoGEF facilitated elevated RhoA activation 
upon FN plating and these effects were inactivated by Y393A or by 
Y1003A or     1292-1301 mutations in GEFH1 and p190RhoGEF, 
respectively (  Fig. 7 B   and not depicted). Interestingly, GFP  –
  p190RhoGEF WT  –  expressing MEFs exhibited a rounded pheno-
type identical to FAK 
   /     MEFs (  Fig. 7 C  ), with an approximately 
threefold increase in FA formation (  Fig. 7 D  ) and inhibited motil-
ity on FN (  Fig. 7 E  ) compared with normal GFP-expressing 
MEFs. As changes in p190RhoGEF expression either prevent or 
stimulate FA formation with corresponding negative effects on 
cell motility, these results point to the importance of p190RhoGEF 
in FA regulation for cell movement. 
  FAK regulation of p190RhoGEF FA 
localization and tyrosine phosphorylation 
  Many regulatory and signaling proteins that participate in integ-
rin signaling events are transiently recruited to FAs upon FN 
plating (  Vicente-Manzanares et al., 2005  ). Although localiza-
tion studies for endogenous p190RhoGEF distribution were in-
conclusive because of high nonspecifi  c staining (not depicted), 
GFP  –  p190RhoGEF WT partially colocalized with paxillin 
at FAs upon FN plating of MEFs (  Fig. 8  ). Interestingly, GFP  –
 p190RhoGEF     1292-1301 with a deletion in the FAK-binding 
region or catalytically inactive GFP  –  p190RhoGEF Y1003A did 
not exhibit strong FA localization (  Fig. 8  ) and did not function 
to facilitate RhoA activation (  Fig. 7 B  ) or alter FA formation 
(  Fig. 7 D  ). This differs from GFP-GEFH1, which was primarily 
cytoplasmic distributed (  Fig. 8  ) and was actively promoting 
FA formation (  Fig. 7 D  ). Although overexpression of GFP  –
 p190RhoGEF     1292-1301 or GFP  –  p190RhoGEF Y1003A had 
weak but signifi  cant (P   <   0.05) inhibitory effects on FN-stimu-
lated motility (  Fig. 7 E  ), this was not associated with alterations 
in cell morphology (  Fig. 8  ) or FA formation (  Fig. 7 D  ) and 
may refl  ect alterations in endogenous p190RhoGEF function. 
Collectively, these results show that although GEFH1 was active 
MEF proliferation. Cell growth assays over 5 d show that FAK 
    /      p190RhoGEF shRNA MEFs grow slower than FAK 
    /      Scr shRNA MEF controls and 
that Ad-Pyk2 overexpression does not function to enhance FAK 
    /      p190RhoGEF shRNA MEF cell proliferation. Cells were infected 24 h before initiating 
growth analyses. Values are means   ±   SD from two experiments. (G) Pyk2 overexpression weakly activates RhoA in FAK 
    /      p190RhoGEF shRNA MEFs. 
Cells were preinfected with Ad-Pyk2 WT, subjected to FN replating, and analyzed for Rho-GTP binding followed by blotting for total RhoA and Myc-
Pyk2 levels.     
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et al., 2006  ) and that a Pyk2-p190RhoGEF signaling linkage 
promotes FAK 
   /     MEF proliferation. 
  Although stable Pyk2 knockdown in FAK 
   /     MEFs  de-
creased paxillin tyrosine phosphorylation to normal levels, the 
most striking finding of our study was that aberrant FAK 
   /    
MEF phenotypes of elevated FA formation, altered F-actin dis-
tribution, and a rounded epithelial-like morphology were linked to 
Pyk2-enhanced p190RhoGEF expression promoting constitutive 
signaling to MAPK activation and increased cell cycle progres-
sion (  Zhao et al., 2003  ). Although Pyk2 overexpression in 
FAK 
   /     MEFs enhances MAPK activation (  Sieg et al., 1998  ), 
we found that Pyk2-enhanced FAK 
   /     MEF proliferation was 
dependent on p190RhoGEF expression and was correlated with 
the ability of Pyk2 to stimulate RhoA activation. This result is 
consistent with the fi  nding that Rho kinase inhibition restored 
adhesion-dependent control of FAK 
   /     MEF proliferation (  Pirone 
  Figure 6.       p190RhoGEF facilitates integrin-associated RhoA regulation, FA formation, and motility of normal MEFs.   (A) Stable p190RhoGEF knockdown. 
FAK 
+/+   MEFs were infected with lentiviral Scr or p190RhoGEF shRNA and sorted for GFP expression and lysates were analyzed by p190RhoGEF, FAK, 
actin, and GFP blotting. (B) p190RhoGEF knockdown limits RhoA activation upon FN adhesion. GTP-bound RhoA was determined by GST-RBD pulldown 
assays from lysates of suspended and FN-replated FAK 
+/+   parental, FAK 
+/+   Scr shRNA, and FAK 
+/+   p190RhoGEF shRNA MEFs, followed by blotting for total 
RhoA levels. (C) Quantitation of FN-stimulated RhoA-GTP binding from assays shown in B. Values are means      SD of two independent experiments and 
are plotted relative to RhoA-GTP levels in suspended FAK 
+/+   MEFs. (D) p190RhoGEF knockdown limits FA formation but not MEF spreading on FN. FAK 
+/+   
Scr and FAK 
+/+   p190RhoGEF shRNA MEFs were plated onto 1-    g/ml-FN  –  coated coverslips for 60 min and costained with antibodies to paxillin and Alexa 
Fluor 350 phalloidin for F-actin. Bar, 30     m. (E) Decreased FA formation upon p190RhoGEF knockdown. Box-and-whisker plots of paxillin-positive  –  stained 
points within FAK 
+/+   Scr shRNA or FAK 
+/+   p190RhoGEF shRNA MEFs plated on FN for 60 min (  n   = 15 cells per point). (F) 10-    g/ml-FN  –  stimulated FAK 
+/+   
(parental), FAK 
+/+   Scr, and FAK 
+/+   p190RhoGEF shRNA MEF Boyden chamber motility over 4 h. Means   ±   SD were determined from three experiments and 
are a percentage of FAK 
+/+   control (set to 100).     197 PYK2 AND FAK CONNECTIONS TO   P  190R  HO  GEF   •   LIM ET AL.
  Figure 7.       p190RhoGEF-stimulated RhoA activity and FA formation are dependent on FAK binding.   (A) GFP-p190RhoGEF or GFP-GEFH1 overexpression in 
normal MEFs. (A) FAK 
+/+   MEFs were infected with a lentiviral expression vector for GFP or GFP fusions of p190RhoGEF WT, p190RhoGEF Y1003A (cata-
lytically inactive), p190RhoGEF     1292-1301 (FAK-binding mutant), GEFH1 WT, or GEFH1 Y393A (catalytically inactive) and sorted for GFP expression. 
Shown is the ﬂ  ow cytometry proﬁ  le of GFP expression (open peaks) compared with FAK 
+/+   autoﬂ  uorescence (shaded peaks). (B) GFP-p190RhoGEF  – 
mediated RhoA activation is dependent on FAK binding. GTP-bound RhoA was determined by GST-RBD pulldown assays from lysates of suspended 
and FN-replated FAK 
+/+  -expressing GFP or the indicated GFP-190RhoGEF constructs followed by blotting for RhoA expression. (C) FAK 
+/+   p190RhoGEF 
WT MEFs show enhanced FA formation and actin ﬁ  bers similar to FAK 
    /      MEFs. Cells were plated onto 1-    g/ml-FN  –  coated coverslips for 60 min and 
costained with antibodies to vinculin and Alexa Fluor 350 phalloidin for F-actin. Bar, 30     m. (D) p190RhoGEF and GEFH1 promote FA formation in MEFs. 
Box-and-whisker plots of paxillin-positive  –  stained points within MEFs stably overexpressing the indicated GFP-p190RhoGEF or GFP-GEFH1 constructs upon 
FN plating for 60 min (  n   = 15 cells per point). (E) GEF-mediated increased FA formation is associated with decreased cell motility. MEFs overexpressing the 
indicated GFP-p190RhoGEF or GFP-GEFH1 constructs were evaluated for 10-    g/ml-FN  –  stimulated Boyden chamber motility over 4 h. Means   ±   SD were 
determined from two experiments and are a percentage of FAK 
+/+   GFP MEFs (set to 100). Asterisks indicate that the difference between FAK 
+/+   GFP and 
FAK 
+/+   GFP  –  p190RhoGEF     1292-1301 or FAK 
+/+   GFP  –  p190RhoGEF Y1003A is signiﬁ  cant (P   <   0.05).     JCB • VOLUME 180 • NUMBER 1 • 2008  198
Y402-dependent signals from Pyk2, but not FAK, regulate 
p190RhoGEF expression in FAK 
   /     MEFs and in PC12 cells. 
Although studies have identifi  ed p190RhoGEF as a protein 
induced by CD40 stimulation of B cells (  Lee et al., 2003  ), the 
important signaling pathways controlling either Pyk2- or CD40-
induced p190RhoGEF expression remain to be defi  ned. 
 In  FAK 
   /     MEFs, stable Pyk2 or p190RhoGEF knock-
down restored normal FN-associated regulation of RhoA activ-
ity and FA formation but these reversals did not enhance cell 
motility. Therefore, deregulated RhoA activity likely contrib-
utes to but is not causal for FAK-null motility defects (  Ren et al., 
2000  ). Importantly, knockdown of GEFH1 that is closely related 
to p190RhoGEF did not reduce FA formation FAK 
   /     MEFs, 
and this further supports the specifi  city of our fi  ndings. Impor-
tantly, Pyk2 or p190RhoGEF knockdown results in FAK 
   /    
MEFs with normal ruffl  ing and lamellipodia formation but these 
cells exhibit tail retraction and severe motility defects. We specu-
late that either cell polarization (  Tilghman et al., 2005  ) or rear 
FA-release defects (  Ren et al., 2000  ) act to limit FAK 
   /     Pyk2 
RhoA activation (  Fig. 10  ). Interestingly, FAK-null keratino-
cytes also display altered actin and FA formation. Pyk2 is ex-
pressed and activated in these cells but it remains unclear 
whether elevated Rho activity in the absence of FAK within 
keratinocytes is associated with a Pyk2-p190RhoGEF signaling 
linkage (  Schober et al., 2007  ). p190RhoGEF is a ubiquitously 
expressed RhoA-specifi  c GEF (  Gebbink et al., 1997  ;   van Horck 
et al., 2001 ). p190RhoGEF contains a central tandem Dbl-pleck-
strin homology domain, an N-terminal leucine-rich region, a 
cysteine-rich zinc fi  nger domain, a large C-terminal domain 
with a potential coiled-coil region shown to bind microtubules 
(  van Horck et al., 2001  ), the 3     untranslated region of neurofi  la-
ment mRNA (  Canete-Soler et al., 2001  ), and FAK (  Zhai et al., 
2003  ). In neuronal cells, p190RhoGEF possesses antiapoptosis 
activity (  Wu et al., 2003  ), is implicated in the pathogenesis of 
motor neuron degeneration (  Lin et al., 2005  ), and plays a nega-
tive role in axonal branching and synapse formation downstream 
of FAK (  Rico et al., 2004  ). Through combined knockdown or 
transient overexpression studies, we found that kinase- and 
  Figure 8.       FAK binding directs p190RhoGEF 
localization to FAs upon FN plating.   FAK 
+/+   
MEFs stably expressing GFP or the indicated 
GFP-p190RhoGEF or GFP-GEFH1 constructs 
were plated onto 1-    g/ml-FN  –  coated coverslips 
for 1 h, ﬁ  xed, and then stained with antibodies 
to paxillin. Shown is the cellular GFP (left) or 
paxillin (middle) distribution and the merged 
images (right). Bar, 30     m.     199 PYK2 AND FAK CONNECTIONS TO   P  190R  HO  GEF   •   LIM ET AL.
  GEFs are multidomain proteins regulated in a complex 
fashion (  Bos et al., 2007  ). This can include protein  –  protein, 
protein – lipid, and second messenger binding and posttransla-
tional modifi  cation of GEFs. These interactions or modifi  ca-
tions can induce GEF translocation to sites of small G protein 
localization, autoinhibition release, or allosteric conformational 
activation of the catalytic region. The importance of FAK in 
p190RhoGEF regulation was supported by comparisons of 
MEFs overexpressing WT or the FAK-binding mutant (   1292-
1301) of p190RhoGEF. Although p190RhoGEF WT partially 
localized to FAs, promoted RhoA activation, and enhanced FA 
formation, p190RhoGEF   1292-1301 overexpression was cyto-
plasmic distributed and did not affect FN-associated RhoA 
activity or FA formation. Although it is also possible that the 
    1292-1301 deletion has global effects on catalytic domain 
folding, overexpressed GEFH1 was not FA localized but still 
functioned similar to p190RhoGEF WT in activating RhoA and 
promoting FA formation. These results support a model whereby 
p190RhoGEF binding to FAK facilitates its localization to and 
activation at FAs, whereas the related GEFH1 does not share 
this mode of regulation. Additionally, p190RhoGEF catalytic 
activity was also important in promoting FA localization through 
undefi  ned mechanisms. As catalytically inactive (Y1003A) 
shRNA MEF motility. As transient FAK reexpression can res-
cue the motility defects of FAK 
   /     Pyk2 shRNA MEFs, stable 
reconstitution with WT FAK and various mutants will yield a 
powerful cell system to elucidate the molecular connections of 
FAK-mediated cell motility. 
  In normal MEFs, reduction in p190RhoGEF expression 
did not affect binding to or spreading on FN, but these cells 
formed fewer FAs under conditions of low RhoA activity. 
FAK 
+/+   p190RhoGEF shRNA MEFs exhibited reduced motility 
on FN, supporting the notion that p190RhoGEF functions as an 
important regulator of RhoA activity and FA formation down-
stream of integrins and is needed for effi  cient cell movement. 
As FN-stimulated FAK and tyrosine phosphorylation was also 
reduced in FAK 
+/+   p190RhoGEF shRNA MEFs (unpublished 
data) and contractility-associated mechanisms within cells can 
facilitate FAK recruitment to and activation at growing FAs 
(  Kirchner et al., 2003  ), our results support the existence of a 
FAK  –  p190RhoGEF regulatory circuit controlling FA formation 
and cell motility (  Fig. 10  ). Additionally, as FAK activation and 
paxillin phosphorylation can infl  uence the distribution of these 
proteins at FAs (  Zaidel-Bar et al., 2007  ), there may be other 
feedback mechanisms limiting FA formation upon p190RhoGEF 
knockdown in normal MEFs. 
  Figure 9.       Adhesion-dependent regulation 
of p190RhoGEF tyrosine phosphorylation.   
(A) GFP-p190RhoGEF is cytoplasmic distributed 
in FAK 
    /      MEFs. Cells were transiently transfected 
with GFP  –  p190RhoGEF WT, plated on FN for 
1 h, and ﬁ  xed and coanalyzed for GFP distri-
bution and paxillin staining as an FA marker. 
Bar, 30     m. (B) p190RhoGEF associates with 
Pyk2. Control rabbit IgG or anti-Pyk2 immuno-
precipitations from FAK 
    /      MEFs were sequen-
tially analyzed by p190RhoGEF and Pyk2 
blotting. (C) p190RhoGEF is tyrosine phos-
phorylated upon FAK 
    /      MEF adhesion to FN. 
Antiphosphotyrosine (pY) immunoprecipitates 
were made from lysates of FAK 
    /      MEFs held 
in suspension or FN replated for 1 h and were 
analyzed by anti-p190RhoGEF blotting. The 
amount of p190RhoGEF in suspended or FN-
replated whole cell lysates (WCLs) was deter-
mined by blotting. (D) The FAK-binding region 
is important for FN-stimulated p190RhoGEF 
tyrosine phosphorylation. Lysates were pre-
pared from FAK 
+/+   MEFs expressing GFP or 
the indicated GFP-p190RhoGEF constructs af-
ter cell suspension or FN replating for 1 h, and 
anti-GFP immunoprecipitates were sequentially 
blotted for phosphotyrosine and GFP. In a sec-
ond experiment, anti-GFP immunoprecipitates 
were sequentially blotted for FAK and paxillin.     JCB • VOLUME 180 • NUMBER 1 • 2008  200
p190RhoGEF could weakly colocalize with FA structures (un-
published data), we speculate that increased numbers of FAs 
formed by WT, but not p190RhoGEF Y1003A overexpression 
infl  uences the equilibrium and distribution of both endogenous 
and exogenous p190RhoGEF localized to FAs in MEFs. 
  One additional level of p190RhoGEF regulation is that 
adhesion-dependent p190RhoGEF tyrosine phosphorylation was 
inhibited by both   1292-1301 and Y1003A mutations. Although 
it remains unclear how phosphorylation may affect p190RhoGEF 
function, this modifi  cation, as well as FAK binding, correlated 
with p190RhoGEF-mediated RhoA activation. Interestingly, 
p190RhoGEF WT did not localize to the many FAs in FAK 
   /    
MEFs yet still functioned to enhance FAK 
   /     FA formation. 
As we fi  nd that p190RhoGEF binds to cytoplasmic-distributed 
Pyk2 within FAK 
   /     MEFs and is tyrosine phosphorylated upon 
FAK 
   /     MEF adhesion to FN, we hypothesize that p190RhoGEF 
activity is regulated in part by FAK and/or Pyk2 binding leading 
to enhanced p190RhoGEF tyrosine phosphorylation. 
  In summary, our studies have uncovered a novel role of 
p190RhoGEF as a mediator of aberrant FAK 
   /     MEF pheno-
types and as an important regulator of FN-associated RhoA 
activation and FA formation in normal MEFs. As the formation 
of too many or too few FAs limit cell movement, future stud-
ies on the regulation of p190RhoGEF activity and the FAK  –
  p190RhoGEF complex will yield important insights into the 
temporal balance of RhoA activity needed for cell migration. 
  Materials and methods 
  Antibodies and reagents 
  mAbs to phosphotyrosine (clone 4G10), vinculin (clone V284), and FAK 
(clone 4.47) were obtained from Millipore. mAbs to p190RhoGAP (clone 
30), Pyk2 (clone 11), paxillin (clone M107), and phosphospeciﬁ  c paxillin 
pTyr-118 (clone 30) were obtained from BD Biosciences. Rabbit polyclonal 
anti-RhoA (sc-179) was obtained from Santa Cruz Biotechnology, Inc. 
Texas red  –  phalloidin and Alexa ﬂ  uor 350 phalloidin were obtained from 
Invitrogen. HA tag (clone 16B12), Myc tag (clone 9E10), GFP (clone B34), 
and Cre recombinase (clone 7.23) mAbs were obtained from Covance 
Research. Anti  –      -actin (clone AC-17) mAb was obtained from Sigma-Aldrich. 
Rabbit polyclonal antibodies (7801/7802) were generated to mouse 
p190RhoGEF residues 1457  –  1582 expressed as a GST fusion protein 
(University of California, San Diego). Antibodies were afﬁ  nity  puriﬁ  ed 
using GST-p190RhoGEF (1457  –  1582) covalently coupled to glutathione 
agarose (Sigma-Aldrich) using dimethylpimelimidate as described previ-
ously (  Sieg et al., 1998  ). Antibody speciﬁ  city was conﬁ  rmed by Western 
blot analysis combined with soluble GST-p190RhoGEF (1457  –  1582) as a 
competitive inhibitor. pCDNA3-Y1003A p190RhoGEF was provided by 
J. Lee (Ewha Womans University, Seoul, Korea). Puriﬁ  ed bovine plasma FN 
was obtained from EMD. 
  Lentiviral constructs 
  shRNA constructs were created using pLentiLox3.7 as previously described 
(  Rubinson et al., 2003  ). Human FAK shRNA was created and used as pre-
viously described (  Mitra et al., 2006a  ). For mouse Pyk2 and p190RhoGEF, 
sense oligos used were as follows: Pyk2, 5    -tGA AGT AGT TCT TAA CCG 
CAT tca aga gAT GCG GTT AAG AAC TAC TTC ttt ttt c-3    ; p190RhoGEF-1, 
5    -tGA ACA GAG ATC ATA TAG TTT tca aga gAA ACT ATA TGA TCT 
CTG TTC ttt ttt c-3    ; p190RhoGEF-2, 5    -tGA ACC AGA CTG TAA TAT CTT 
tca aga gAA GAT ATT ACA GTA TGG TTC TTT TTT C-3    ; and Scr, 5    -tGT 
CTC CGA ACG TGT CAC GTT tca aga gAA CGT GAT ACG TTC GGA 
GAC ttt ttt c-3    . The 5    t belongs to the U6 promoter and lowercase letters 
represent components of the shRNA loop. The 3    c was added to generate 
an XhoI site. Antisense oligos used were as follows: Pyk2, 5    -tcg aga aaa 
aaG AAG TAG TTC TTA ACC GCA T  ct ctt ga  A TGC GGT TAA GAA CTA 
CTT Ca-3    ; p190RhoGEF-1, 5    -tcg aga aaa aaG AAC AGA GAT CAT ATA 
GTT T  ct ctt ga  A AAC TAT ATG ATC TCT GTT Ca-3    ; p190RhoGEF-2, 5    -tcg 
  Figure 10.       Model of p190RhoGEF function in FAK   
    /        and FAK 
+/+   MEFs.   
Elevated Pyk2 levels and signaling in FAK 
    /      MEFs promote p190RhoGEF 
mRNA and protein expression. Knockdown of Pyk2 reduces FAK 
    /      prolif-
eration, whereas Pyk2 reexpression enhances cell growth that is dependent 
on p190RhoGEF expression. Pyk2 phosphorylates p190RhoGEF, Pyk2 
forms a complex with p190RhoGEF that is cytoplasmic distributed, and 
Pyk2-p190RhoGEF acts to promote aberrant RhoA activation connected to 
enhanced FAK 
    /      MEF FA formation. Knockdown of Pyk2 or p190RhoGEF 
in FAK 
    /      MEFs restores normal integrin-regulated RhoA activity and FA 
formation but do not rescue FAK 
    /      MEF motility defects that involve lack 
of FA release. In normal MEFs, transient RhoA inhibition after FN plating is 
mediated in part through Src phosphorylation and activation of p190RhoGAP 
(  Arthur et al., 2000  ). p190RhoGEF knockdown limits RhoA activation and 
FA formation upon FN plating, whereas p190RhoGEF overexpression 
overrides p190RhoGAP-mediated RhoA regulation to promote RhoA acti-
vation and enhanced FA formation and recapitulates a partial FAK 
    /      cell 
phenotype. Both p190RhoGEF overexpression and knockdown prevent 
cell movement as the formation of too many or too few FAs limits motil-
ity. p190RhoGEF transiently localizes to FAs upon FN replating. This is 
dependent on FAK binding and is associated with p190RhoGEF tyrosine 
phosphorylation. Unlike other cytoplasmic GEFs, such as GEFH1, that can 
activate RhoA, the ability of p190RhoGEF to stimulate RhoA is associated 
with FAK-Pyk2 binding, tyrosine phosphorylation, or FA localization. This 
paper has elucidated a novel role for p190RhoGEF as an integrin-proximal 
regulator of FA formation and cell motility.     201 PYK2 AND FAK CONNECTIONS TO   P  190R  HO  GEF   •   LIM ET AL.
(Millipore) were coated on the both sides with 10   μ  g/ml FN for 2 h at 
room temperature. Membranes were washed with PBS and air dried for 
2 h. Cells were suspended by limited EDTA-trypsin treatment, washed by 
0.25 mg/ml soybean trypsin inhibitor in DME, suspended in Migration 
medium (0.5% BSA in DME), and counted. 5   ×   10 
4   cells in 0.3 ml (held in 
suspension for 1 h) were added to each MilliCell chamber and incubated 
for 4 h at 37  °  C. Cells were ﬁ  xed and stained with crystal violet. Each data 
point represents three individual chambers enumerated as previously de-
scribed (  Hsia et al., 2005  ). For scratch-wound assays, cells were seeded 
in six-well plates and starved for 24 h. Cells were wounded by scratching 
with pipette tip, washed with PBS, photographed (0-h point), and placed 
into growth media containing 0.5   μ  g/ml mitomycin-C to block cell division. 
After 16 h, matched-pair wound regions were photographed. For phase-
contrast time-lapse video microscopy, cells were plated onto 1-  μ  g/ml-FN  –
  coated glass coverslips in growth media. After 3 h, images were collected 
with a charge coupled device camera (Orca 285; Hamamatsu) at 5-min 
intervals over 4 h with a 20  ×   lens on an automated (Metamorph 6.3; Uni-
versal Imaging Corporation) microscope (Nikon TE300) with a heated and 
motorized stage. For each experiment, 12 individual cell ﬁ  elds were re-
corded. Cell trajectories were measured by tracking the position of the cell 
nucleus over time. Cells that did not spread or remain within the ﬁ  eld of 
view during the experimental period were not evaluated. For cell prolifera-
tion assays, 5   ×   10 
5   cells were plated into 6-well plates precoated with 
0.5% gelatin and grown in DME with 10% FBS. At 24-h intervals, two 
wells were trypsinized and individually enumerated using an automated 
hemocytometer. Each experiment was repeated three times. One-way 
analysis of variance was used to determine statistical signiﬁ  cance for pro-
liferation and motility assays. 
  Immunoﬂ  uorescent staining 
  Cells were plated onto 10-  μ  g/ml-FN  –  coated glass coverslips in the ab-
sence of serum for the indicated times. Cells were ﬁ  xed in 3.7% para-
formaldehyde for 15 min and permeabilized with 0.1% Triton X-100 for 
10 min. Blocking was performed with 100   μ  g/ml ChromPure donkey IgG in 
PBS (Jackson ImmunoResearch Laboratories) at room temperature for 1 h. 
Vinculin (1:50) or paxillin (1:50) antibodies were diluted in PBS and incu-
bated overnight at 4  °  C. After three washes in PBS, coverslips were incu-
bated for 45 min in PBS containing rhodamine-conjugated donkey 
anti  –  mouse IgG and ﬂ   uorescein-conjugated phalloidin to visualize actin 
stress ﬁ  bers. In cells expressing GFP or GFP fusion proteins, actin was visu-
alized with Alexa Fluor 350 phalloidin. After washing, coverslips were 
mounted in Vectashield (Vector Laboratories). Images from wide UV (excita-
tion, 330  –  85 nm; dichroic mirror, 400 nm; emission, 420 nm), wide blue 
(excitation, 450  –  80 nm; dichroic mirror, 500 nm; emission, 515 nm), and 
wide green (excitation, 510  –  550 nm; dichroic mirror, 570 nm; emission, 
590 nm) were sequentially captured at 60  ×   (UPLFL objective, 1.25 NA; 
Olympus) using a controller (MAC5000) and shutter (LEP; Ludl), a mono-
chrome charge-coupled device camera (ORCA ER; Hamamatsu), an in-
verted microscope (IX51; Olympus), and Openlab software (Improvision). 
Images were pseudocolored using Image J 1.38 and overlayed and 
merged using Photoshop CS3 (Adobe). Integrated morphometry analysis 
was performed using Image J 1.38 on thresholded images to select classi-
ﬁ  ed objects of a size range of 0.1  –  20 pixels as FAs, based on anti-paxillin 
staining. The analyze particles command was used to measure both FA 
size and number. F-actin intensity was measured on spread cells stained 
with FITC-conjugated or Alexa Flour 350 phalloidin using Image J analysis 
of mean pixel intensity within a deﬁ  ned region of interest. 
  Mouse GEFH1 (Arhgef2), Scr siRNA, and siGLO green transfection 
indicator were obtained from Dharmacon. 100 pmol siRNA + 100 pmol 
siGLO was used to transfect (Lipofectamine 2000) FAK 
    /      or FAK 
+/+   MEFs. 
After 48 h, GEFH1 knockdown was conﬁ  rmed by blotting (  Birkenfeld et al., 
2007  ). Cells were starved overnight, trypsinized, suspended for 1 h, and 
plated onto coverslips coated with 10   μ  g/ml FN for 1 h. Cells were ﬁ  xed 
with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and 
costained for actin and paxillin using standard methods. 
  Online supplemental material 
  Fig. S1 shows scratch-wound healing motility defects of FAK 
    /      Pyk2 shRNA 
MEFs. Fig. S2 shows time-lapse analyses of random MEF motility. Fig. S3 
shows that GEFH1 knockdown does not affect FN-associated FA formation. 
Fig. S4 shows the differential localization of GEFH1 and p190RhoGEF in 
MEFs. Fig. S5 shows that FAK, Pyk2, and Src can directly phosphorylate 
p190RhoGEF in vitro. Videos 1  –  4 show random motility of the indicated 
MEFs plated on 1-  μ  g/ml-FN  –  coated glass slides in the presence of 10% 
FBS at 37  °  C. Phase-contrast images were obtained every 5 min for 10 h. 
Files were sharpened and contrast-adjusted using Photoshop. Videos were 
aga aaa aaG AAC CAG ACT GTA ATA TCT Tct ctt gaA AGA TAT TAC 
AGT CTG GTT Ca-3    ; and Scr, 5    -tcg aga aaa aaG TCT CCG AAC GTG 
TCA CGT T  ct ctt ga  A ACG TGA CAC GTT CGG AGA Ca-3    . An addi-
tional four nucleotides at the 5     end were added to generate XhoI site. 
pLentiLox3.7 expresses the shRNA and GFP from distinct promoters, and 
virus production was achieved by 293T cell transfection as previously de-
scribed (  Mitra et al., 2006a  ). Media containing viruses was used to infect 
target cells after 48 h. To create N-terminal GFP fusions of p190RhoGEF 
WT, p190RhoGEF Y1003A and     1292-1301 RhoGEF (  Zhai et al., 2003  ) 
were digested with KpnI and XbaI and cloned into the same sites within 
pEGFPC2. For lentiviral expression, GFP-p190RhoGEF was removed by 
NheI  –  XbaI digestion and cloned into NheI  –  SwaI  –  digested pCDH1-MCS1 
(System Biosciences). GFP  –  GEFH1 WT and catalytically inactive Y393A 
(  Krendel et al., 2002  ) were removed from pCMV5 by EcoR1  –  ClaI diges-
tion and blunt-end cloned into pCDH1-MSC1. Viruses were produced by 
293T cell transfection, concentrated by polyethylene glycol precipitation, 
and used to infect target cells. 
  RT-PCR 
  Total RNA was extracted with Trizol reagent (Invitrogen) and cDNA was 
synthesized from 5   μ  g using SuperScript ﬁ  rst-strand synthesis system for 
RT-PCR (Invitrogen). A 1-  μ  l aliquot of the reverse-transcription reaction 
was then used for subsequent PCR ampliﬁ  cations. Primers used were the 
following: p190RhoGEF forward, 5    -GAGCAAGGAGGTAACAGAACT-3    ; 
p190RhoGEF reverse, 5    -CGCCATCGGAAGACTTAGTT-3    ;     -actin for-
ward, 5    -TGTGATGGTGGGAATGGGTCAG-3    ; and     -actin reverse, 5    -TTT  -
GATGTCACGCACGATTTCC-3    . p190RhoGEF was ampliﬁ  ed for 30 cycles 
and primers for actin were added after cycle 10. 
  Cell culture and viruses 
  FAK 
(loxP/loxP)   mice (  Beggs et al., 2003  ) were obtained from H. Beggs (Uni-
versity of California, San Francisco, San Francisco, CA) and were crossed 
with p53-null mice (  Ilic et al., 1995  ). Embryonic day  –  8.5 mouse embryos 
were isolated, placed within a drop of Matrigel (BD BioSciences), and cul-
tured for 10 d. MEFs that grew out of embryos were disaggregated, plated 
onto 10-  μ  g/ml-FN  –  coated dishes, and expanded. At passage two, 1/3 of 
MEFs were used for genomic DNA isolation genotype conﬁ  rmation, 1/3 
were expanded, and 1/3 were transduced with Ad-Cre recombinase at 
25 MOI. Cre protein expression was detected at 48 h of infection but was 
undetectable after 7 d and subsequent passages. FAK 
+/+  , FAK 
    /     , and 
FAK-reconstituted (DP3) MEFs are p53-null and were maintained as de-
scribed previously (  Sieg et al., 1999  ). Human diploid ﬁ  broblasts  and 
PC12 cells were obtained from American Type Culture Collection. Human 
ﬁ  broblasts were grown in the same media as mouse MEFs (  Sieg et al., 
1999  ). PC12 cells were grown in DME with 5% horse serum, 10% FBS, 
50 U/ml penicillin, and 50   μ  g/ml streptomycin. Recombinant adenovirus 
for HA-tagged FAK, Myc-tagged Pyk2, Myc-tagged Pyk2 F402, and Myc-
tagged Pyk2 A457 in pADtet7 contain Tet-responsive enhancer sequences 
within a minimal cytomegalovirus promoter, and expression was driven by 
coinfection with Ad-Tet transactivator as previously described (  Hsia et al., 
2005  ). Cells were infected at 5 MOI per cell for Ad-TA and at 50 MOI for 
Ad-FAK or Ad-Pyk2 constructs. Lentiviral-infected ﬁ  broblasts  expressing 
GFP, GFP-p190RhoGEF, or GFP-GEFH1 were obtained by FACS and main-
tained as pool populations. 
  Cell lysis, immunoprecipitation, blotting, and pulldown assays 
  Cells were washed in ice-cold PBS and solubilized in modiﬁ  ed RIPA lysis 
buffer containing 1% Triton X-100, 0.5% sodium deoxycholate, and 0.1% 
SDS (  Sieg et al., 1998  ). For immunoprecipitations, 2.5   μ  g of antibodies 
were incubated with lysates (each sample containing 500  –  1,000   μ  g of 
  total protein) for 3 h at 4  °  C and collected by binding to protein G plus or 
protein A  –  agarose beads. SDS-PAGE, antibody blotting, and sequential 
membrane reprobing was performed as previously described (  Sieg et al., 
1998  ). Rho activity was measured by pulldown assays using GST  –  Rhotekin 
Rho binding domain (GST-RBD) (  Ren et al., 2000  ). Clariﬁ  ed RIPA cell 
lysates were incubated with 20   μ  g GST-RBD beads at 4  °  C for 45 min and 
beads were washed four times with buffer B (Tris buffer containing 1% 
Triton X-100, 150 mM NaCl, 10 mM MgCl  2  , 10   μ  g/ml leupeptin, 10   μ  g/ml 
aprotinin, and 0.1 mM PMSF). Bound Rho proteins were detected by poly-
clonal RhoA blotting. Image J version1.37 (National Institutes of Health) 
was used to obtain densitometric values from blots, and Rho activity was 
determined as the amount of RBD-bound Rho versus total Rho in the lysate. 
  Cell migration and proliferation assays 
  For cell migration assays, cells were used 48 h after Ad infection and 
serum starved in 0.5% FBS overnight. Millicell chambers with 8-    m pores JCB • VOLUME 180 • NUMBER 1 • 2008  202
   Medley ,   Q.G. ,   E.G.    Buchbinder ,   K.    Tachibana ,   H.    Ngo ,   C.    Serra-Pages , and   M.   
  Streuli  .   2003  .   Signaling between focal adhesion kinase and trio.       J. Biol. 
Chem.     278 : 13265  –  13270 .  
   Mitra ,   S.K. ,  and   D.D.    Schlaepfer .   2006  .   Integrin-regulated FAK-Src signaling in 
normal and cancer cells.       Curr. Opin. Cell Biol.     18 : 516  –  523 .  
   Mitra ,   S.K. ,   D.A.    Hanson ,  and   D.D.    Schlaepfer .   2005  .   Focal adhesion kinase: in 
command and control of cell motility.       Nat. Rev. Mol. Cell Biol.     6 : 56  –  68 .  
   Mitra ,   S.K. ,   S.T.    Lim ,   A.    Chi ,  and   D.D.    Schlaepfer .   2006a  .   Intrinsic focal adhe-
sion kinase activity controls orthotopic breast carcinoma metastasis via 
the regulation of urokinase plasminogen activator expression in a synge-
neic tumor model.       Oncogene   .    25 : 4429  –  4440 .  
   Mitra ,   S.K. ,   D.    Mikolon ,   J.E.    Molina ,   D.A.    Hsia ,   D.A.    Hanson ,   A.    Chi ,   S.T.  
 Lim ,   J.A.    Bernard-Trifi   lo ,   D.    Ilic ,   D.G.    Stupack ,   et  al .   2006b .   Intrinsic 
FAK activity and Y925 phosphorylation facilitate an angiogenic switch in 
tumors.     Oncogene   .    25 : 5969  –  5984 .  
   Moissoglu ,   K. ,  and   M.A.    Schwartz .   2006  .   Integrin signalling in directed cell 
migration.     Biol. Cell   .    98 : 547  –  555 .  
   Okigaki ,   M. ,   C.    Davis ,   M.    Falasca ,   S.    Harroch ,   D.P.    Felsenfeld  ,   M.P.     Sheetz ,  and 
  J.     Schlessinger  .   2003  .   Pyk2 regulates multiple signaling events crucial 
for macrophage morphology and migration.       Proc. Natl. Acad. Sci. USA   .  
 100 : 10740  –  10745 .  
   Owen ,   J.D. ,   P.J.    Ruest ,   D.W.    Fry ,  and   S.K.    Hanks .   1999 .   Induced  focal  adhesion 
kinase (FAK) expression in FAK-null cells enhances cell spreading and 
migration requiring both auto- and activation loop phosphorylation sites 
and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2.       Mol. 
Cell. Biol.     19 : 4806  –  4818 .  
   Pirone ,   D.M. ,   W.F.    Liu ,   S.A.    Ruiz ,   L.    Gao ,   S.    Raghavan ,   C.A.    Lemmon ,   L.H.  
  Romer  , and   C.S.     Chen  .   2006  .   An inhibitory role for FAK in regulating 
proliferation: a link between limited adhesion and RhoA-ROCK signal-
ing.     J. Cell Biol.     174 : 277  –  288 .  
   Ren ,   X.D. ,   W.B.    Kiosses ,  and   M.A.    Schwartz .   1999 .   Regulation  of  the  small 
GTP-binding protein Rho by cell adhesion and the cytoskeleton.       EMBO J.   
 18 : 578  –  585 .  
   Ren ,   X.D. ,   W.B.    Kiosses ,   D.J.    Sieg ,   C.A.    Otey ,   D.D.    Schlaepfer , and   M.A.   
 Schwartz .   2000  .   Focal adhesion kinase suppresses Rho activity to pro-
mote focal adhesion turnover.       J. Cell Sci.     113 : 3673  –  3678 .  
   Ren ,   Y. ,   R.    Li ,   Y.    Zheng ,  and   H.    Busch .   1998 .   Cloning  and  characterization  of 
GEF-H1, a microtubule-associated guanine nucleotide exchange factor 
for Rac and Rho GTPases.       J. Biol. Chem.     273 : 34954  –  34960 .  
   Rico ,   B. ,   H.E.    Beggs ,   D.    Schahin-Reed ,   N.    Kimes ,   A.    Schmidt ,  and   L.F.  
  Reichardt  .   2004  .   Control of axonal branching and synapse formation by 
focal adhesion kinase.       Nat. Neurosci.     7 : 1059  –  1069 .  
   Ridley ,  A.J. ,   M.A.    Schwartz ,   K.    Burridge ,   R.A.    Firtel ,   M.H.    Ginsberg ,   G.    Borisy , 
 J.T.    Parsons ,  and   A.R.    Horwitz .   2003 .   Cell  migration:  integrating  signals 
from front to back.       Science   .    302 : 1704  –  1709 .  
   Romer ,   L.H. ,   K.G.    Birukov ,  and   J.G.    Garcia .   2006 .   Focal  adhesions:  paradigm 
for a signaling nexus.       Circ. Res.     98 : 606  –  616 .  
   Rossman ,   K.L. ,   C.J.    Der ,  and   J.    Sondek .   2005 .   GEF  means  go:  turning  on  RHO 
GTPases with guanine nucleotide-exchange factors.       Nat. Rev. Mol. Cell 
Biol.     6 : 167  –  180 .  
   Rubinson ,   D.A. ,   C.P.    Dillon ,  A.V.    Kwiatkowski ,   C.    Sievers ,   L.   Yang ,   J.    Kopinja , 
 D.L.    Rooney ,   M.M.    Ihrig ,   M.T.    McManus ,   F.B.    Gertler ,   et  al .   2003 . 
  A lentivirus-based system to functionally silence genes in primary 
mammalian cells, stem cells and transgenic mice by RNA interference.   
  Nat. Genet.     33 : 401  –  406 .  
   Schiller ,   M.R.     2006  .   Coupling receptor tyrosine kinases to Rho GTPases  –  GEFs 
what ’ s  the  link.     Cell. Signal.     18 : 1834  –  1843 .  
   Schober ,   M. ,   S.    Raghavan ,   M.    Nikolova ,   L.    Polak ,   H.A.    Pasolli ,   H.E.    Beggs , 
 L.F.    Reichardt ,  and   E.    Fuchs .   2007 .   Focal  adhesion  kinase  modulates  ten-
sion signaling to control actin and focal adhesion dynamics.       J. Cell Biol.   
 176 : 667  –  680 .  
   Sieg ,   D.J. ,   D.    Ilic ,   K.C.    Jones ,   C.H.    Damsky ,   T.    Hunter , and   D.D.     Schlaepfer  . 
  1998  .   Pyk2 and Src-family protein-tyrosine kinases compensate for 
the loss of FAK in fi  bronectin-stimulated signaling events but Pyk2 
does not fully function to enhance FAK 
 
    cell migration.       EMBO J.   
 17 : 5933  –  5947 .  
   Sieg ,   D.J. ,   C.R.    Hauck ,  and   D.D.    Schlaepfer .   1999  .   Required role of focal 
adhesion kinase (FAK) for integrin-stimulated cell migration.       J. Cell Sci.   
 112 : 2677  –  2691 .  
   Tilghman ,   R.W. ,   J.K.    Slack-Davis ,   N.    Sergina ,   K.H.    Martin ,   M.    Iwanicki ,   E.D.  
 Hershey ,   H.E.    Beggs ,   L.F.    Reichardt ,  and   J.T.    Parsons .   2005 .   Focal  adhe-
sion kinase is required for the spatial organization of the leading edge in 
migrating cells.       J. Cell Sci.     118 : 2613  –  2623 .  
   van  Horck ,   F.P. ,   M.R.    Ahmadian ,   L.C.    Haeusler ,   W.H.    Moolenaar , and   O.  
 Kranenburg .   2001 .   Characterization  of  p190RhoGEF,  a  RhoA-specifi  c 
guanine nucleotide exchange factor that interacts with microtubules.   
  J. Biol. Chem.     276 : 4948  –  4956 .  
created using QuickTime Pro (Apple), Cinepak compression, at 450   ×   375 
pixel frame size. Each ﬁ  le represents 105 sequential images (8 h and 
45 min) at 15 frames per second. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200708194/DC1. 
  This project was supported by National Institutes of Health grant CA87038 to 
D. Schlaepfer. Y. Lim was supported in part by Korea Research Foundation 
grant M01-2005-000-10071-0. M. Gardel was supported by a Jane 
Cofﬁ  n Childs fellowship. W. Schlaepfer is supported by grant NS515722, 
C. Waterman-Storer by grant GM67230, and D. Schlaepfer by grants 
CA75240 and CA102310 from the National Institutes of Health. C. Waterman-
Storer and D. Schlaepfer are Established Investigators of the American 
Heart Association. 
Submitted:   29 August 2007 
Accepted:   12 December 2007 
  References 
   Arthur ,   W.T. ,   L.A.    Petch ,  and   K.    Burridge .   2000 .   Integrin  engagement  suppresses 
RhoA activity via a c-Src-dependent mechanism.       Curr. Biol.     10 : 719  –  722 .  
   Beggs ,   H.E. ,   D.    Schahin-Reed ,   K.    Zang ,   S.    Goebbels ,   K.A.    Nave ,   J.    Gorski ,   K.R.  
 Jones ,   D.    Sretavan ,  and   L.F.    Reichardt .   2003 .   FAK  defi  ciency in cells 
contributing to the basal lamina results in cortical abnormalities resem-
bling congenital muscular dystrophies.       Neuron   .    40 : 501  –  514 .  
   Birkenfeld ,   J. ,   P.    Nalbant ,   B.P.    Bohl ,   O.    Pertz ,   K.M.    Hahn ,  and   G.M.    Bokoch . 
  2007  .   GEF-H1 modulates localized RhoA activation during cytokinesis 
under the control of mitotic kinases.       Dev. Cell   .    12 : 699  –  712 .  
   Bos ,   J.L. ,   H.    Rehmann ,  and   A.    Wittinghofer .   2007  .   GEFs and GAPs: critical 
elements in the control of small G proteins.       Cell   .    129 : 865  –  877 .  
   Canete-Soler ,   R. ,   J.    Wu ,   J.    Zhai ,   M.    Shamim ,  and   W.W.    Schlaepfer .   2001 . 
  p190RhoGEF Binds to a destabilizing element in the 3     untranslated 
region of light neurofi  lament subunit mRNA and alters the stability of 
the transcript.       J. Biol. Chem.     276 : 32046  –  32050 .  
   Chen ,   B.H. ,   J.T.    Tzen ,   A.R.    Bresnick ,  and   H.C.    Chen .   2002 .   Roles  of  Rho-
associated kinase and myosin light chain kinase in morphological and 
migratory defects of focal adhesion kinase-null cells.       J. Biol. Chem.   
 277 : 33857  –  33863 .  
   Chikumi ,   H. ,   S.    Fukuhara ,  and   J.S.    Gutkind .   2002 .   Regulation  of  G  protein-
linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and 
LARG by tyrosine phosphorylation: evidence of a role for focal adhesion 
kinase.     J. Biol. Chem.     277 : 12463  –  12473 .  
   Gebbink ,   M.F. ,   O.    Kranenburg ,   M.    Poland ,   F.P.    van  Horck ,   B.    Houssa ,  and   W.H.  
 Moolenaar .   1997 .   Identifi  cation of a novel, putative Rho-specifi  c GDP/
GTP exchange factor and a RhoA-binding protein: control of neuronal 
morphology.     J. Cell Biol.     137 : 1603  –  1613 .  
   Geiger ,   B. ,  and  A.    Bershadsky .   2001 .  Assembly  and  mechanosensory  function  of 
focal contacts.       Curr. Opin. Cell Biol.     13 : 584  –  592 .  
   Hall ,   A.    2005 .   Rho  GTPases  and  the  control  of  cell  behaviour.     Biochem. Soc. 
Trans.     33 : 891  –  895 .  
   Holinstat ,   M. ,   N.    Knezevic ,   M.    Broman ,   A.M.    Samarel ,   A.B.    Malik ,  and   D.  
  Mehta  .   2006  .   Suppression of RhoA activity by focal adhesion kinase-
induced activation of p190RhoGAP: role in regulation of endothelial 
permeability.     J. Biol. Chem.     281 : 2296  –  2305 .  
   Hsia ,   D.A. ,   S.T.    Lim ,   J.A.    Bernard-Trifi   lo ,   S.K.    Mitra ,   S.    Tanaka ,   J.    den  Hertog , 
 D.N.    Streblow ,   D.    Ilic ,   M.H.    Ginsberg ,  and   D.D.    Schlaepfer .   2005  . 
 Integrin   { alpha } 4 { beta } 1  promotes  focal  adhesion  kinase-independent 
cell motility via   { alpha } 4  cytoplasmic  domain-specifi  c  activation  of 
c-Src.     Mol. Cell. Biol.     25 : 9700  –  9712 .  
   Ilic ,   D. ,  Y.    Furuta ,   S.    Kanazawa ,   N.    Takeda ,   K.    Sobue ,   N.    Nakatsuji ,   S.    Nomura , 
 J.    Fujimoto ,   M.    Okada ,   T.   Yamamoto ,  and   S.   Aizawa .   1995 .   Reduced  cell 
motility and enhanced focal adhesion contact formation in cells from 
FAK-defi  cient mice.       Nature   .    377 : 539  –  544 .  
   Kirchner ,   J. ,   Z.    Kam ,   G.    Tzur ,   A.D.    Bershadsky ,  and   B.    Geiger .   2003 .   Live-cell 
monitoring of tyrosine phosphorylation in focal adhesions following 
microtubule disruption.       J. Cell Sci.     116 : 975  –  986 .  
   Krendel ,   M. ,   F.T.    Zenke  ,  and   G.M.    Bokoch .   2002 .   Nucleotide  exchange  factor 
GEF-H1 mediates cross-talk between microtubules and the actin cyto-
skeleton.       Nat. Cell Biol.     4 : 294  –  301 .  
   Lee ,   J.R. ,   Y.J.    Ha ,  and   H.J.    Kim .   2003 .   Cutting  edge:  induced  expression  of  a 
RhoA-specifi  c guanine nucleotide exchange factor, p190RhoGEF, fol-
lowing CD40 stimulation and WEHI 231 B cell activation.       J. Immunol.   
 170 : 19  –  23 .  
   Lin ,   H. ,   J.    Zhai ,  and   W.W.    Schlaepfer  .   2005  .   RNA-binding protein is involved in 
aggregation of light neurofi  lament protein and is implicated in the patho-
genesis of motor neuron degeneration.       Hum. Mol. Genet.     14 : 3643  –  3659 .  203 PYK2 AND FAK CONNECTIONS TO   P  190R  HO  GEF   •   LIM ET AL.
   Vicente-Manzanares ,   M. ,   D.J.    Webb ,  and   A.R.    Horwitz .   2005 .   Cell  migration  at 
a glance.       J. Cell Sci.     118 : 4917  –  4919 .  
   Webb ,   D.J. ,   C.M.    Brown ,  and   A.F.    Horwitz .   2003 .   Illuminating  adhesion  com-
plexes in migrating cells: moving toward a bright future.       Curr. Opin. Cell 
Biol.     15 : 614  –  620 .  
   Webb ,   D.J. ,   K.    Donais ,   L.A.    Whitmore ,   S.M.    Thomas ,   C.E.    Turner ,   J.T.    Parsons , 
and   A.F.    Horwitz .   2004 .   FAK-Src  signalling  through  paxillin,  ERK  and 
MLCK regulates adhesion disassembly.       Nat. Cell Biol.     6 : 154  –  161 .  
   Wehrle-Haller ,   B. ,  and   B.    Imhof .   2002 .  The  inner  lives  of  focal  adhesions.      Trends 
Cell Biol.     12 : 382  –  389 .  
   Wu ,   J. ,   J.    Zhai ,   H.    Lin ,   Z.    Nie ,  W.W.    Ge ,   L.    Garcia-Bermejo ,   R.J.    Muschel ,  W.W.  
 Schlaepfer , and   R.     Canete-Soler  .   2003  .   Cytoplasmic retention sites in 
p190RhoGEF confer anti-apoptotic activity to an EGFP-tagged protein.   
  Brain Res. Mol. Brain Res.     117 : 27  –  38 .  
   Zaidel-Bar ,   R. ,   C.    Ballestrem ,   Z.    Kam ,  and   B.    Geiger .   2003 .   Early  molecular 
events in the assembly of matrix adhesions at the leading edge of migrating 
cells.     J. Cell Sci.     116 : 4605  –  4613 .  
   Zaidel-Bar ,  R. ,  M.   Cohen ,  L.   Addadi , and  B.   Geiger .  2004 .  Hierarchical assembly 
of cell-matrix adhesion complexes.       Biochem. Soc. Trans.     32 : 416  –  420 .  
   Zaidel-Bar ,   R. ,   R.    Milo ,   Z.    Kam ,  and   B.    Geiger .   2007 .   A  paxillin  tyrosine 
phosphorylation switch regulates the assembly and form of cell-matrix 
adhesions.     J. Cell Sci.     120 : 137  –  148 .  
   Zhai ,   J. ,   H.    Lin ,   Z.    Nie ,   J.    Wu ,   R.    Canete-Soler ,   W.W.    Schlaepfer ,  and   D.D.  
  Schlaepfer  .   2003  .   Direct interaction of focal adhesion kinase with 
p190RhoGEF.     J. Biol. Chem.     278 : 24865  –  24873 .  
   Zhao ,   J. ,   Z.C.    Bian ,   K.    Yee ,   B.P.    Chen ,   S.    Chien ,  and   J.L.    Guan .   2003 . 
 Identifi  cation of transcription factor KLF8 as a downstream target of 
focal adhesion kinase in its regulation of cyclin D1 and cell cycle progression.   
  Mol. Cell   .    11 : 1503  –  1515 .              